These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 25773416)
21. Comparing the efficacy of 308-nm light-emitting diode and 308-nm excimer lamp for treating vitiligo: A randomized controlled trial. Hu Y; Liu L; Xu Z; Huang D; Chen H; Zhang J; Chen L; Dai X; Zhang L; Luan C; Ju M; Chen K Photodermatol Photoimmunol Photomed; 2024 May; 40(3):e12972. PubMed ID: 38752300 [TBL] [Abstract][Full Text] [Related]
22. A cross-sectional, comparative study of home vs in-office NB-UVB phototherapy for vitiligo. Dillon JP; Ford C; Hynan LS; Pandya AG Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):282-283. PubMed ID: 28660721 [No Abstract] [Full Text] [Related]
23. Narrowband ultraviolet B phototherapy in childhood vitiligo: evaluation of results in 28 patients. Percivalle S; Piccinno R; Caccialanza M; Forti S Pediatr Dermatol; 2012; 29(2):160-5. PubMed ID: 22329609 [TBL] [Abstract][Full Text] [Related]
24. Surgical treatment is indicated in long-duration segmental vitiligo. Lee DY; Park JH; Lee JH; Yang JM; Lee ES Dermatol Surg; 2010 Apr; 36(4):568-9. PubMed ID: 20402936 [No Abstract] [Full Text] [Related]
25. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study. Sapam R; Agrawal S; Dhali TK Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369 [TBL] [Abstract][Full Text] [Related]
26. Self-administration of hospital-based narrowband ultraviolet B (TL-01) phototherapy: a feasibility study in an outpatient setting. Yule S; Sanyal S; Ibbotson S; Moseley H; Dawe RS Br J Dermatol; 2013 Aug; 169(2):464-8. PubMed ID: 23488569 [TBL] [Abstract][Full Text] [Related]
27. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy. Yones SS; Palmer RA; Garibaldinos TM; Hawk JL Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217 [TBL] [Abstract][Full Text] [Related]
28. The 308-nm excimer laser: a promising device for the treatment of childhood vitiligo. Cho S; Zheng Z; Park YK; Roh MR Photodermatol Photoimmunol Photomed; 2011 Feb; 27(1):24-9. PubMed ID: 21198879 [TBL] [Abstract][Full Text] [Related]
29. Broadband targeted UVB phototherapy for localized vitiligo: a retrospective study. Akar A; Tunca M; Koc E; Kurumlu Z Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):161-3. PubMed ID: 19438998 [TBL] [Abstract][Full Text] [Related]
30. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156 [TBL] [Abstract][Full Text] [Related]
31. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients. Linthorst Homan MW; Spuls PI; Nieuweboer-Krobotova L; de Korte J; Sprangers MA; Bos JD; Wolkerstorfer A; van der Veen JP J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):690-5. PubMed ID: 21711467 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: a randomized intra-individual open comparative trial. Satyanarayan HS; Kanwar AJ; Parsad D; Vinay K Indian J Dermatol Venereol Leprol; 2013; 79(4):525-7. PubMed ID: 23760325 [No Abstract] [Full Text] [Related]
33. The effect of 308nm excimer laser on segmental vitiligo: a retrospective study of 80 patients with segmental vitiligo. Do JE; Shin JY; Kim DY; Hann SK; Oh SH Photodermatol Photoimmunol Photomed; 2011 Jun; 27(3):147-51. PubMed ID: 21535168 [TBL] [Abstract][Full Text] [Related]
35. Narrowband ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of generalized vitiligo. Gamil H; Attwa E; Ghonemy S Clin Exp Dermatol; 2010 Dec; 35(8):919-21. PubMed ID: 20456387 [No Abstract] [Full Text] [Related]
36. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study. Lahiri K; Malakar S; Sarma N; Banerjee U Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620 [TBL] [Abstract][Full Text] [Related]
37. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study. Shin J; Lee JS; Hann SK; Oh SH Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270 [TBL] [Abstract][Full Text] [Related]
38. The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration. Park JH; Park SW; Lee DY; Lee JH; Yang JM Photodermatol Photoimmunol Photomed; 2013 Apr; 29(2):103-5. PubMed ID: 23458396 [TBL] [Abstract][Full Text] [Related]
39. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients. Fai D; Cassano N; Vena GA J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000 [TBL] [Abstract][Full Text] [Related]
40. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy. Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]